Department of Anesthesiology, University Hospital, LMU, Munich, Germany.
Division of Animal Physiology and Immunology, School of Life Sciences Weihenstephan, Technical University of Munich, Freising, Germany.
Front Immunol. 2021 Dec 9;12:784028. doi: 10.3389/fimmu.2021.784028. eCollection 2021.
Extracellular vesicles (EVs) are mediators of cell-to-cell communication in inflammatory lung diseases. They function as carriers for miRNAs which regulate mRNA transcripts and signaling pathways after uptake into recipient cells. We investigated whether miRNAs associated with circulating EVs regulate immunologic processes in COVID-19.
We prospectively studied 20 symptomatic patients with COVID-19 pneumonia, 20 mechanically ventilated patients with severe COVID-19 (severe acute respiratory corona virus-2 syndrome, ARDS) and 20 healthy controls. EVs were isolated by precipitation, total RNA was extracted, profiled by small RNA sequencing and evaluated by differential gene expression analysis (DGE). Differentially regulated miRNAs between groups were bioinformatically analyzed, mRNA target transcripts identified and signaling networks constructed, thereby comparing COVID-19 pneumonia to the healthy state and pneumonia to severe COVID-19 ARDS.
DGE revealed 43 significantly and differentially expressed miRNAs (25 downregulated) in COVID-19 pneumonia when compared to controls, and 20 miRNAs (15 downregulated) in COVID-19 ARDS patients in comparison to those with COVID-19 pneumonia. Network analysis for comparison of COVID-19 pneumonia to healthy controls showed upregulated miR-3168 (log2FC=2.28, p<0.001), among others, targeting interleukin-6 (IL6) (25.1, 15.2 - 88.2 pg/ml in COVID-19 pneumonia) and OR52N2, an olfactory smell receptor in the nasal epithelium. In contrast, miR-3168 was significantly downregulated in COVID-19 ARDS (log2FC=-2.13, p=0.003) and targeted interleukin-8 (CXCL8) in a completely activated network. Toll-like receptor 4 (TLR4) was inhibited in COVID-19 pneumonia by miR-146a-5p and upregulated in ARDS by let-7e-5p.
EV-derived miRNAs might have important regulative functions in the pathophysiology of COVID-19: CXCL8 regulates neutrophil recruitment into the lung causing epithelial damage whereas activated TLR4, to which SARS-CoV-2 spike protein binds strongly, increases cell surface ACE2 expression and destroys type II alveolar cells that secrete pulmonary surfactants; both resulting in pulmonary-capillary leakage and ARDS. These miRNAs may serve as biomarkers or as possible therapeutic targets.
细胞外囊泡 (EVs) 是炎症性肺部疾病中细胞间通讯的介质。它们作为 miRNA 的载体,在被受体细胞摄取后调节 mRNA 转录本和信号通路。我们研究了与循环 EV 相关的 miRNA 是否调节 COVID-19 中的免疫过程。
我们前瞻性研究了 20 例有症状的 COVID-19 肺炎患者、20 例接受机械通气的严重 COVID-19(严重急性呼吸冠状病毒 2 综合征,ARDS)患者和 20 例健康对照者。通过沉淀分离 EVs,提取总 RNA,进行小 RNA 测序并通过差异基因表达分析 (DGE) 进行评估。对组间差异调节的 miRNA 进行生物信息学分析,鉴定 mRNA 靶转录本并构建信号网络,从而将 COVID-19 肺炎与健康状态和肺炎与严重 COVID-19 ARDS 进行比较。
与对照组相比,COVID-19 肺炎患者的 DGE 显示出 43 个显著差异表达的 miRNA(25 个下调),而 COVID-19 ARDS 患者与 COVID-19 肺炎患者相比则有 20 个 miRNA(15 个下调)。将 COVID-19 肺炎与健康对照者进行比较的网络分析显示,miR-3168(log2FC=2.28,p<0.001)等上调,其靶标为白细胞介素 6(IL6)(COVID-19 肺炎患者中为 25.1、15.2-88.2pg/ml)和嗅上皮中的嗅觉受体 OR52N2。相比之下,miR-3168 在 COVID-19 ARDS 中显著下调(log2FC=-2.13,p=0.003),并在完全激活的网络中靶向白细胞介素 8(CXCL8)。miR-146a-5p 抑制 COVID-19 肺炎中的 Toll 样受体 4(TLR4),而 let-7e-5p 在 ARDS 中上调。
EV 衍生的 miRNA 可能在 COVID-19 的病理生理学中具有重要的调节作用:CXCL8 调节中性粒细胞向肺部募集,导致上皮损伤,而强烈结合 SARS-CoV-2 刺突蛋白的 TLR4 则增加细胞表面 ACE2 的表达并破坏分泌肺表面活性剂的 II 型肺泡细胞;两者均导致肺毛细血管渗漏和 ARDS。这些 miRNA 可以作为生物标志物或可能的治疗靶点。